Randomized double-blind placebo-controlled phase II/III trial in adjuvant NSCLC patients with the candidate cancer vaccine IGN101

被引：1
|
作者：
Loibner, H.
Eckert, H.
Stoiber, W.
Groiss, F.
Stoelben, E.
机构：
[1] HL Biosci Res, Vienna, Austria
[2] Altropus, Arlesheim, Switzerland
[3] Krankenhaus Merheim, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3012
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized placebo-controlled phase II study with the cancer vaccine candidate IGN101 in patients with epithelial cancers.
    Himmler, G
    Settaf, A
    Groiss, F
    Eller, N
    Salzberg, M
    Kundi, M
    Eckert, H
    Loibner, H
    Samonigg, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 179S - 179S
  • [2] A Randomized placebo-controlled phase II study with the cancer vaccine IGN101 in patients with epithelial cancers
    Settaf, A
    Salzberg, M
    Groiss, F
    Eller, N
    Schuster, M
    Himmler, G
    Kundi, M
    Eckert, H
    Loibner, H
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S32 - S32
  • [3] A randomized placebo-controlled phase II study with the cancer vaccine IGN101 in patients with epithelial solid organ tumors (IGN101/2-01)
    Loibner, H
    Eckert, H
    Eller, N
    Groiss, F
    Himmler, G
    Rosenkaimer, F
    Salzberg, R
    Samonigg, H
    Schuster, M
    Settaf, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 192S - 192S
  • [4] Exploratory analysis of gender and age aspects in a finished placebo-controlled randomized trial with the cancer vaccine IGN101 in 762 NSCLC patients in the adjuvant setting
    Loibner, Hans
    Groiss, Franz
    Stoelben, Erich
    CANCER RESEARCH, 2009, 69
  • [5] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Masato Murakami
    Kenichi Osada
    Hiromichi Mizuno
    Toshimitsu Ochiai
    Levent Alev
    Kusuki Nishioka
    Arthritis Research & Therapy, 17
  • [6] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [7] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [8] Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy
    Saadipoor, Afshin
    Razzaghdoust, Abolfazl
    Simforoosh, Nasser
    Mahdavi, Arash
    Bakhshandeh, Mohsen
    Moghadam, Maryam
    Abdollahi, Hamid
    Mofid, Bahram
    PHYTOTHERAPY RESEARCH, 2019, 33 (02) : 370 - 378
  • [9] Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy
    Vansteenkiste, J
    Pirker, R
    Massuti, B
    Barata, F
    Font, A
    Fiegl, M
    Siena, S
    Gateley, J
    Tomita, D
    Colowick, AB
    Musil, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (16) : 1211 - 1220
  • [10] Low Lymphocyte and Neutrophil Counts at Start of Vaccinations With the Cancer Vaccine IGN101 Predict Improved Relapse-free Survival-results of a Randomized Phase II/III Trial in Adjuvant NSCLC
    Loibner, Hans
    Groiss, Franz
    Eckert, Helmut
    Stoiber, Wolfgang
    Stoelben, Erich
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 944 - 944
12345